U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279727) titled 'Ultrasound-Guided Infraclvicular Block Using Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Upper Limb Orthopedic Surgery' on Nov. 27.
Brief Summary: this study is designed to evaluate and compare the efficacy of dexmedetomidine and nalbuphine as adjuvants to 0.5% bupivacaine in ultrasound-guided infraclavicular brachial plexus block for patients undergoing elective upper limb orthopedic surgeries on the duration of analgesia.
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Regional Anaesthesia
Intervention:
DRUG: Nalbuphine
Nalbuphine will be added to .5% bupivacaine as an adjuvant in ...